Celling Biosciences Competitors and Similar CompaniesClear all
Orthocell's competitors and similar companies include InGeneron and Celldex Therapeutics.
 Orthocell Orthocell is a company that develops devices for regenerating mobility of tendon, cartilage, and soft tissue. |  InGeneron InGeneron is a cell therapy company that offers treatments designed to heal certain chronic conditions using a patient’s own regenerative cells. |  Celldex Therapeutics Celldex Therapeutics (formerly Avant Immunotherapeutics) is a biopharmaceutical company that specializes in monoclonal and bispecific antibodies development. | |
Founding Date | Founding Date 2006 | Founding Date 2006 | Founding Date 1983 |
Type | Type Public | Type Private | Type Public |
Tags | |||
Locations | Locations Murdoch, AU HQ | Locations Houston, US HQ München, DE | Locations Hampton, US HQ Fall River, US Needham, US New Haven, US |
Employees | Employees N/A | Employees 16 | Employees 1608% increase |
Valuation ($) | Valuation ($) 65.5 m | Valuation ($) N/A | Valuation ($) 1.9 b |
Financial | |||
Revenue (est.) | Revenue (est.) $7.6m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $1.5m (FY, 2025) |
Cost of goods | Cost of goods $2.2m (FY, 2025) | Cost of goods N/A | Cost of goods $200k (FY, 2025) |
Gross profit | Gross profit $5.7m (FY, 2025) | Gross profit N/A | Gross profit $1.3m (FY, 2025) |
Net income | Net income ($8.6m) (FY, 2025) | Net income N/A | Net income ($258.8m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 47.5m | Total funding raised $ 2m |
For sources of this data, please see the company profile
View Company Profiles
InGeneron
HQ
Houston, US
Employees
16
InGeneron is a cell therapy company that offers treatments designed to heal certain chronic conditions using a patient’s own regenerative cells.
View companyCelldex Therapeutics
HQ
Hampton, US
Employees
160↑ 8% increase
Celldex Therapeutics (formerly Avant Immunotherapeutics) is a biopharmaceutical company that specializes in monoclonal and bispecific antibodies development.
View company